339 related articles for article (PubMed ID: 18827057)
1. Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2008 Oct; 17(10):922-30. PubMed ID: 18827057
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome.
Rand JH
J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894
[TBL] [Abstract][Full Text] [Related]
3. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.
Rand JH; Wu XX; Quinn AS; Taatjes DJ
Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989
[TBL] [Abstract][Full Text] [Related]
4. Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.
Chen PP; Yang CD; Ede K; Wu CC; FitzGerald JD; Grossman JM
Lupus; 2008 Oct; 17(10):916-21. PubMed ID: 18827056
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibody syndrome: new insights on thrombogenic mechanisms.
Rand JH
Am J Med Sci; 1998 Aug; 316(2):142-51. PubMed ID: 9704667
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome.
Rand JH; Wu XX; Lapinski R; van Heerde WL; Reutelingsperger CP; Chen PP; Ortel TL
Blood; 2004 Nov; 104(9):2783-90. PubMed ID: 15242878
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Lupus; 2008 Oct; 17(10):872-7. PubMed ID: 18827051
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
[TBL] [Abstract][Full Text] [Related]
11. The pathogenic role of annexin-V in the antiphospholipid syndrome.
Rand JH
Curr Rheumatol Rep; 2000 Jun; 2(3):246-51. PubMed ID: 11123066
[TBL] [Abstract][Full Text] [Related]
12. Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug.
Rand JH; Wu XX; Quinn AS; Ashton AW; Chen PP; Hathcock JJ; Andree HA; Taatjes DJ
Blood; 2010 Mar; 115(11):2292-9. PubMed ID: 19965621
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated interference with annexins in the antiphospholipid syndrome.
Rand JH; Wu XX
Thromb Res; 2004; 114(5-6):383-9. PubMed ID: 15507268
[TBL] [Abstract][Full Text] [Related]
14. Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.
de Laat B; Wu XX; van Lummel M; Derksen RH; de Groot PG; Rand JH
Blood; 2007 Feb; 109(4):1490-4. PubMed ID: 17053060
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy].
Peluso G; Morrone G
Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401
[TBL] [Abstract][Full Text] [Related]
16. Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes.
Wolgast LR; Arslan AA; Wu XX; Beyda JN; Pengo V; Rand JH
J Thromb Haemost; 2017 Jul; 15(7):1412-1421. PubMed ID: 28393472
[TBL] [Abstract][Full Text] [Related]
17. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
18. Annexin A2: biology and relevance to the antiphospholipid syndrome.
Cockrell E; Espinola RG; McCrae KR
Lupus; 2008 Oct; 17(10):943-51. PubMed ID: 18827060
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool.
Tomer A; Bar-Lev S; Fleisher S; Shenkman B; Friger M; Abu-Shakra M
Br J Haematol; 2007 Oct; 139(1):113-20. PubMed ID: 17854315
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome.
Rand JH; Wu XX
Thromb Haemost; 1999 Aug; 82(2):649-55. PubMed ID: 10605763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
